Related Articles
Impact of metastatic status on the prognosis of EGFR mutation‑positive non‑small cell lung cancer patients treated with first‑generation EGFR‑tyrosine kinase inhibitors
Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non‑squamous non-small‑cell lung cancer
Radiation therapy following targeted therapy in oligometastatic renal cell carcinoma
Pleural effusion and pulmonary injury as an unusual complication to chemotherapy in non-small cell lung cancer patients.
Specific organ metastases and survival in metastatic non‑small‑cell lung cancer